Having trouble viewing this email? View in your browser.
  31st European Congress of Clinical Microbiology & Infectious Diseases
09 - 12 July 2021 • ECCMID 2021 • Virtual meeting


Rachel Dawson

Global Director Medical Affairs
Pneumococcal Vaccines

ESCMID Appointed Chair

Mario Ramirez

Faculdade de Medicina
Universidade de Lisboa
Instituto de Microbiologia
Instituto de Medicina Molecular
Lisbon, Portugal



Carmen Ardanuy Tisaire

Head of Molecular Diagnostic Section
Department of Clinical Microbiology
Hospital Universitari de Bellvitge
L'Hospitalet de Llobregat, Spain

Aisling Caffrey

Director of Infectious Disease Health Outcomes Research Veterans Affairs
Providence Healthcare System
Associate Professor of Health Outcomes
University of Rhode Island
College of Pharmacy
Kingston, Rhode Island, USA

Daniel Musher

Distinguished Service
Professor of Medicine and Professor of Molecular Virology and Microbiology
Baylor College of Medicine
Houston, Texas, USA

Adult pneumococcal vaccination: Evidence to inform optimal policy for at-risk groups and the role of polysaccharide vaccines

Saturday, 10 July 2021

13:15 - 14:45 (CEST)

Chair: Rachel Dawson
ESCMID Appointed Chair: Mario Ramirez


13:15 - 13:20 Introduction and opening remarks
Rachel Dawson
13:20 - 13:35 Serotype epidemiology of pneumococcal disease in patients with chronic medical conditions
Carmen Ardanuy
13:35 - 13:55 Pneumococcal disease risk stacking and its implications for adult vaccination policy
Aisling Caffrey
13:55 - 14:20 Recent studies on the effectiveness of pneumococcal polysaccharide vaccines
Daniel Musher
14:20 - 14:40 Discussion and Q&A
All speakers
14:40 - 14:45 Closing remarks
Rachel Dawson

Agenda may be subject to change pending speaker confirmation
  © MSD Merck Sharp & Dohme AG, Werftestrasse 4, 6005 Lucerne, Switzerland. All rights reserved. CH-NON-01270 created 07/21


You have received this email as a contact of ESCMID or one of its affiliated societies.
You can unsubscribe here.